Enhanced histaminergic neurotransmission and sleep-wake alterations, a study in histamine H3-receptor knock-out mice

Neuropsychopharmacology

Volumn 38, Issue 6, 2013, Pages 1015-1031

  Gondard, Elise ^a   Anaclet, Christelle ^a   Akaoka, Hidéo ^a   Guo, Rui Xian ^a,c   Zhang, Mei ^a,d   Buda, Colette ^a   Franco, Patricia ^a   Kotani, Hidehito ^b,e   Lin, Jian Sheng ^a  

^a UNIVERSITÉ LYON 1   (France)

^b BANYU PHARMACEUTICAL CO LTD   (Japan)

^c SUN YAT SEN UNIVERSITY   (China)

^d GUANGZHOU MEDICAL UNIVERSITY   (China)

^e MERCK RESEARCH LABORATORIES   (United States)

Author keywords

behavior; H3 receptor; histamine; motivation; sleep; wakefulness

Indexed keywords

ALPHA FLUOROMETHYLHISTIDINE; CIPROXIFAN; HISTAMINE H3 RECEPTOR; HISTAMINE RECEPTOR; TRIPROLIDINE;

ANIMAL EXPERIMENT; AROUSAL; ARTICLE; DESENSITIZATION; ELECTROCORTICOGRAPHY; FEMALE; MALE; MOUSE; NEUROTRANSMISSION; NONHUMAN; OBESITY; PHENOTYPE; PRIORITY JOURNAL; SLEEP DISORDER; SLEEP WAKING CYCLE; SLOW WAVE SLEEP;

ANIMALS; FEMALE; HISTAMINE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, HISTAMINE H3; SLEEP; SLEEP STAGES; SYNAPTIC TRANSMISSION; UP-REGULATION; WAKEFULNESS;

EID: 84878528264     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2012.266     Document Type: Article

References (59)

1. Abe H, Honma S, Ohtsu H, Honma K (2004). Circadian rhythms in behavior and clock gene expressions in the brain of mice lacking histidine decarboxylase. Brain Res Mol Brain Res 124: 178-187.
2. Anaclet C, Parmentier R, Ouk K, Guidon G, Buda C, Sastre JP et al (2009). Orexin/hypocretin and histamine: distinct roles in the control of wakefulness demonstrated using knock-out mouse models. J Neurosci 29: 14423-14438.
3. Arrang JM, Garbarg M, Schwartz JC (1983). Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor. Nature 302: 832-837.
4. Barbier AJ, Berridge C, Dugovic C, Laposky AD, Wilson SJ, Boggs J et al (2004). Acute wake-promoting actions of JNJ-5207852, a novel, diamine-based H3 antagonist. Br J Pharmacol 143: 649-661.
5. Bonaventure P, Letavic M, Dugovic C, Wilson S, Aluisio L, Pudiak C et al (2007). Histamine H3 receptor antagonists: from target identification to drug leads. Biochem Pharmacol 73: 1084-1096.
6. Brown RE, Stevens DR, Haas HL (2001). The physiology of brain histamine. Prog Neurobiol 63: 637-672.
7. Esbenshade TA, Browman KE, Bitner RS, Strakhova M, Cowart MD, Brioni JD (2008). The histamine H3 receptor: an attractive target for the treatment of cognitive disorders. Br J Pharmacol 154: 1166-1181.
8. Garbarg M, Barbin G, Rodergas E, Schwartz JC (1980). Inhibition of histamine synthesis in brain by alpha-fluoromethylhistidine, a new irreversible inhibitor: in vitro and in vivo studies. J Neurochem 35: 1045-1052.
9. Gondard E, Anaclet A, Zhang M, Buda C, Sastre JP, Guidon G et al (2008). Sleep-wake regulation by histamine and its H3-receptors: study using knock-out mouse model. Annual meeting of Societe Francaise de Recherche et Medicine du Sommeil (SFRMS), 2008 Lille, France
10. Gondard E, Anaclet A, Zhang M, Guo RX, Buda C, Sastre JP et al (2010). Increased Histaminergic Neurotransmission and Sleep-Wake Alterations, Study in Histamine H3-Receptor Knock-out Mice, 20th Congress of the European Sleep Research Society (ESRS), Lisbon, Portuguese. J Sleep Res 19: 571
11. Guo RX, Anaclet C, Roberts JC, Parmentier R, Zhang M, Guidon G et al (2009). Differential effects of acute and repeat dosing with the H3 antagonist GSK189254 on the sleep-wake cycle and narcoleptic episodes in Ox-/- mice. Br J Pharmacol 157: 104-117.
12. Haas HL, Sergeeva OA, Selbach O (2008). Histamine in the nervous system. Physiol Rev 88: 1183-1241.
13. Hajos M, Siok CJ, Hoffmann WE, Li S, Kocsis B (2008). Modulation of hippocampal theta oscillation by histamine H3 receptors. J Pharmacol Exp Ther 324: 391-398.
14. Hong ST, Bang S, Paik D, Kang J, Hwang S, Jeon K et al (2006). Histamine and its receptors modulate temperature-preference behaviors in Drosophila. J Neurosci 26: 7245-7256.
15. Inoue I, Yanai K, Kitamura D, Taniuchi I, Kobayashi T, Niimura K et al (1996). Impaired locomotor activity and exploratory behavior in mice lacking histamine H1 receptors. Proc Natl Acad Sci USA 93: 13316-13320.
16. Jones BE (2005). From waking to sleeping: neuronal and chemical substrates. Trends Pharmacol Sci 26: 578-586.
17. Kiyono S, Seo ML, Shibagaki M, Watanabe T, Maeyama K, Wada H (1985). Effects of alpha-fluoromethylhistidine on sleep-waking parameters in rats. Physiol Behav 34: 615-617.
18. Kollonitsch J, Perkins LM, Patchett AA, Doldouras GA, Marburg S, Duggan DE et al (1978). Selective inhibitors of biosynthesis of aminergic neurotransmitters. Nature 274: 906-908.
19. Ligneau X, Landais L, Perrin D, Piriou J, Uguen M, Denis E et al (2007). Brain histamine and schizophrenia: potential therapeutic applications of H3-receptor inverse agonists studied with BF2.649. Biochem Pharmacol 73: 1215-1224.
20. Ligneau X, Lin JS, Vanni-Mercier G, Jouvet M, Muir JL, Ganellin CR et al (1998). Neurochemical and behavioral effects of ciproxifan, a potent histamine H3-receptor antagonist. J Pharmacol Exp Ther 287: 658-666.
21. Ligneau X, Perrin D, Landais L, Camelin JC, Calmels TP, Berrebi-Bertrand I et al (2006). BF2.649 [1-{3-[3-(4-Chlorophenyl) propoxy]propyl}piperidine, hydrochloride], a nonimidazole inverse agonist/antagonist at the human histamine H3 receptor: Preclinical pharmacology. J Pharmacol Exp Ther 320: 365-375.
22. Lin JS (2000). Brain structures and mechanisms involved in the control of cortical activation and wakefulness, with emphasis on the posterior hypothalamus and histaminergic neurons. Sleep Med Rev 4: 471-503.
23. Lin JS, Anaclet C, Sergeeva OA, Haas HL (2011b). The waking brain: an update. Cell Mol Life Sci 68: 2499-2512.
24. Lin JS, Dauvilliers Y, Arnulf I, Bastuji H, Anaclet C, Parmentier R et al (2008). An inverse agonist of histamine H(3)receptor improves wakefulness in narcolepsy: studies in orexin -/- mice and patients. Neurobiol Dis 30: 74-83.
25. Lin JS, Hou Y, Sakai K, Jouvet M (1996). Histaminergic descending inputs to the mesopontine tegmentum and their role in the control of cortical activation and wakefulness in the cat. J Neurosci 16: 1523-1537.
26. Lin JS, Kitahama K, Fort P, Panula P, Denney RM, Jouvet M (1993). Histaminergic system in the cat hypothalamus with reference to type B monoamine oxidase. J Comp Neurol 330: 405-420.
27. Lin JS, Luppi PH, Salvert D, Sakai K, Jouvet M (1986). [Histamineimmunoreactive neurons in the hypothalamus of cats]. C R Acad Sci III 303: 371-376.
28. Lin JS, Sakai K, Jouvet M (1988). Evidence for histaminergic arousal mechanisms in the hypothalamus of cat. Neuropharmacology 27: 111-122.
29. Lin JS, Sakai K, Vanni-Mercier G, Arrang JM, Garbarg M, Schwartz JC et al (1990). Involvement of histaminergic neurons in arousal mechanisms demonstrated with H3-receptor ligands in the cat. Brain Res 523: 325-330.
30. Lin JS, Sergeeva OA, Haas HL (2011a). Histamine H3 receptors and sleep-wake regulation. J Pharmacol Exp Therap 336: 17-23.
31. Maeyama K, Watanabe T, Taguchi Y, Yamatodani A, Wada H (1982). Effect of alpha-fluoromethylhistidine, a suicide inhibitor of histidine decarboxylase, on histamine levels in mouse tissues. Biochem Pharmacol 31: 2367-2370.
32. Masaki T, Chiba S, Yasuda T, Noguchi H, Kakuma T, Watanabe T et al (2004). Involvement of hypothalamic histamine H1 receptor in the regulation of feeding rhythm and obesity. Diabetes 53: 2250-2260.
33. Masaki T, Yoshimatsu H (2006). The hypothalamic H1 receptor: a novel therapeutic target for disrupting diurnal feeding rhythm and obesity. Trends Pharmacol Sci 27: 279-284.
34. McCormick DA (1992). Neurotransmitter actions in the thalamus and cerebral cortex and their role in neuromodulation of thalamocortical activity. Prog Neurobiol 39: 337-388.
35. McCormick DA, Williamson A (1991). Modulation of neuronal firing mode in cat and guinea pig LGNd by histamine: possible cellular mechanisms of histaminergic control of arousal. J Neurosci 11: 3188-3199.
36. Monti JM (1993). Involvement of histamine in the control of the waking state. Life Sci 53: 1331-1338.
37. Monti JM, D'Angelo L, Jantos H, Pazos S (1988). Effects of a-fluoromethylhistidine on sleep and wakefulness in the rat. Short note. J Neural Transm 72: 141-145.
38. Moruzzi G (1972). The sleep-waking cycle. Ergeb Physiol 64: 1-165.
39. Nuutinen S, Lintunen M, Vanhanen J, Ojala T, Rozov S, Panula P (2011). Evidence for the role of histamine H3 receptor in alcohol consumption and alcohol reward in mice. Neuropsychopharmacol 36: 2030-2040.
40. Panula P, Yang HY, Costa E (1984). Histamine-containing neurons in the rat hypothalamus. Proc Natl Acad Sci USA 81: 2572-2576.
41. Parmentier R, Anaclet C, Guhennec C, Brousseau E, Bricout D, Giboulot T et al (2007). The brain H3-receptor as a novel therapeutic target for vigilance and sleep-wake disorders. Biochem Pharmacol 73: 1157-1171.
42. Parmentier R, Ohtsu H, Djebbara-Hannas Z, Valatx JL, Watanabe T, Lin JS (2002). Anatomical, physiological, and pharmacological characteristics of histidine decarboxylase knock-out mice: evidence for the role of brain histamine in behavioral and sleep-wake control. J Neurosci 22: 7695-7711.
43. Passani MB, Lin JS, Hancock A, Crochet S, Blandina P (2004). The histamine H3 receptor as a novel therapeutic target for cognitive and sleep disorders. Trends Pharmacol Sci 25: 618-625.
44. Revel FG, Gottowik J, Gatti S, Wettstein JG, Moreau JL (2009). Rodent models of insomnia: a review of experimental procedures that induce sleep disturbances. Neurosci Biobehav Rev 33: 874-899.
45. Rizk A, Curley J, Robertson J, Raber J (2004). Anxiety and cognition in histamine H3 receptor-/- mice. Eur J Neurosci 19: 1992-1996.
46. Sakai K, El Mansari M, Lin JS, Zhang JG, Vanni-Mercier G (1990). The posterior hypothalamus in the regulation of wakefulness and paradoxical sleep. In: Mancia M, Marini G (eds.) The diencephalon and sleep. Raven: New York, pp 171-198.
47. Schwartz JC, Arrang JM, Garbarg M, Pollard H, Ruat M (1991). Histaminergic transmission in the mammalian brain. Physiol Rev 71: 1-51.
48. Spiegel K, Leproult R, Van Cauter E (1999). Impact of sleep debt on metabolic and endocrine function. Lancet 354: 1435-1439.
49. Spiegel K, Tasalie E, Penev P, Van Cauter E (2004). Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann Intern Med 141: 846-850.
50. Takahashi K, Lin JS, Sakai K (2006). Neuronal activity of histaminergic tuberomammillary neurons during wake-sleep states in the mouse. J Neurosci 26: 10292-10298.
51. Takahashi K, Suwa H, Ishikawa T, Kotani H (2002). Targeted disruption of H3 receptors results in changes in brain histamine tone leading to an obese phenotype. J Clin Invest 110: 1791-1799.
52. Tokita S, Takahashi K, Kotani H (2006). Recent advances in molecular pharmacology of the histamine systems: physiology and pharmacology of histamine H3 receptor: roles in feeding regulation and therapeutic potential for metabolic disorders. J Pharmacol Sci 101: 12-18.
53. Toyota H, Dugovic C, Koehl M, Laposky AD, Weber C, Ngo K et al (2002). Behavioral characterization of mice lacking histamine H(3) receptors. Mol Pharmacol 62: 389-397.
54. Turrigiano GG (2008). The self-tuning neuron: synaptic scaling of excitatory synapses. Cell 135: 422-435.
55. Valatx JL (1971). Long-term recording of cerebral, muscular and ocular electric activities in mice. C R Seances Soc Biol Fil 165: 112-115.
56. Valatx JL, Bugat R (1974). [Genetic factors as determinants of the waking-sleep cycle in the mouse (author's transl)]. Brain Res 69: 315-330.
57. Vanni-Mercier G, Gigout S, Debilly G, Lin JS (2003). Waking selective neurons in the posterior hypothalamus and their response to histamine H3-receptor ligands: an electrophysiological study in freely moving cats. Behav Brain Res 144: 227-241.
58. Watanabe T, Taguchi Y, Shiosaka S, Tanaka J, Kubota H, Terano Y et al (1984). Distribution of the histaminergic neuron system in the central nervous system of rats; a fluorescent immunohistochemical analysis with histidine decarboxylase as a marker. Brain Res 295: 13-25.
59. Yanai K, Watanabe T, Hatazawa J, Itoh M, Nunoki K, Hatano K et al (1990). Visualization of histamine H1 receptors in dog brain by positron emission tomography. Neurosci Lett 118: 41-44.